Verve Shares Soar After New Gene-Editing Trial Shows No Safety Concerns
Verve Therapeutics Inc. shares jumped after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol.
The Boston-based company said its treatment was well-tolerated with no serious treatment-related adverse events among 14 participants in an early-stage trial. The treatment led to an average reduction in cholesterol of 53%, according to a statement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Rocky Mountain Chocolate: Fiscal Q4 Earnings Snapshot
DURANGO, Colo. (AP) — DURANGO, Colo. (AP) — Rocky Mountain Chocolate Factory Inc. (RMCF) on Tuesday reported a loss of $2.9 million in its fiscal fourth quarter. On a per-share basis, the Durango, Colorado-based company said it had a loss of 37 cents. The confectionery producer and retailer posted revenue of $8.9 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on RMCF at
Yahoo
44 minutes ago
- Yahoo
Tsakos: Q1 Earnings Snapshot
ATHENS, Greece (AP) — ATHENS, Greece (AP) — Tsakos Energy Navigation Ltd. (TEN) on Tuesday reported net income of $37.7 million in its first quarter. On a per-share basis, the Athens, Greece-based company said it had net income of $1.04. Earnings, adjusted for non-recurring gains, came to 92 cents per share. The oil and gas shipping company posted revenue of $197.1 million in the period. Its adjusted revenue was $161 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TEN at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
44 minutes ago
- Yahoo
Bitcoin Rewards Firm Fold Secures $250M Facility to Expand BTC Holdings
Fold (FLD), a publicly traded bitcoin financial services company, has secured an equity purchase facility worth up to $250 million to grow its bitcoin BTC holdings. The Arizona-based firm said on Tuesday it signed an agreement granting it the right, but not the obligation, to issue and sell up to $250 million in new shares, pending regulatory conditions. If activated, Fold plans to direct most of the proceeds toward expanding its corporate bitcoin treasury, which already holds 1,490 BTC. The facility was arranged through Cohen & Company Capital Markets, a division of J.V.B. Financial Group, while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
